130 related articles for article (PubMed ID: 22098387)
1. High-dose esomeprazole is required for intraesophageal acid control in gastroesophageal reflux disease patients with hiatus hernia.
Peng S; Xiao YL; Cui Y; Lin JK; Zhang N; Hu PJ; Chen MH
J Gastroenterol Hepatol; 2012 May; 27(5):893-8. PubMed ID: 22098387
[TBL] [Abstract][Full Text] [Related]
2. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
Peng S; Xiong LS; Xiao YL; Wang AJ; Lin JK; Hu PJ; Chen MH
Chin Med J (Engl); 2010 Aug; 123(15):2012-7. PubMed ID: 20819534
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG
Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412
[TBL] [Abstract][Full Text] [Related]
4. GERD assessment including pH metry predicts a high response rate to PPI standard therapy.
Kandulski A; Peitz U; Mönkemüller K; Neumann H; Weigt J; Malfertheiner P
BMC Gastroenterol; 2013 Jan; 13():12. PubMed ID: 23324360
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.
Hatlebakk JG; Zerbib F; Bruley des Varannes S; Attwood SE; Ell C; Fiocca R; Galmiche JP; Eklund S; Långström G; Lind T; Lundell LR;
Clin Gastroenterol Hepatol; 2016 May; 14(5):678-85.e3. PubMed ID: 26226096
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus.
Yeh RW; Gerson LB; Triadafilopoulos G
Dis Esophagus; 2003; 16(3):193-8. PubMed ID: 14641308
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Placebo-Controlled
Sierra-Arango F; Castaño DM; Forero JD; Pérez-Riveros ED; Ardila Duarte G; Botero ML; Cárdenas A; De la Hoz-Valle J
Can J Gastroenterol Hepatol; 2019; 2019():3926051. PubMed ID: 31929980
[TBL] [Abstract][Full Text] [Related]
8. Dual Ambulatory pH Monitoring in Patients with Gastroesophageal Reflux Rendered Asymptomatic with Proton Pump Inhibitor Therapy.
Lin D; Triadafilopoulos G
Dig Dis Sci; 2015 May; 60(5):1343-9. PubMed ID: 25135815
[TBL] [Abstract][Full Text] [Related]
9. [Repeated dual-probe pH monitoring as a diagnostic tool to control therapy for laryngopharyngeal reflux].
Reichel O; Durst F; Rasp G; Berghaus A
HNO; 2007 Oct; 55(10):798-803. PubMed ID: 17431571
[TBL] [Abstract][Full Text] [Related]
10. Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study).
Lu B; Zhang L; Wang J; Wang B; Zou X; Fei G; Chen D; Wang X; Wu B; Zou D
J Gastroenterol Hepatol; 2018 Oct; 33(10):1722-1727. PubMed ID: 29575167
[TBL] [Abstract][Full Text] [Related]
11. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
Beaumont H; Boeckxstaens GE
Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
[TBL] [Abstract][Full Text] [Related]
12. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study.
Bajbouj M; Becker V; Phillip V; Wilhelm D; Schmid RM; Meining A
Digestion; 2009; 80(2):112-8. PubMed ID: 19641320
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect on symptoms and quality of life of maintenance therapy with esomeprazole 20 mg daily: a post hoc analysis of the LOTUS trial.
Lundell L; Hatlebakk J; Galmiche JP; Attwood SE; Ell C; Fiocca R; Persson T; Nagy P; Eklund S; Lind T
Curr Med Res Opin; 2015 Jan; 31(1):65-73. PubMed ID: 25350223
[TBL] [Abstract][Full Text] [Related]
14. Control of acid and duodenogastroesophageal reflux (DGER) in patients with Barrett's esophagus.
Yachimski P; Maqbool S; Bhat YM; Richter JE; Falk GW; Vaezi MF
Am J Gastroenterol; 2015 Aug; 110(8):1143-8. PubMed ID: 26032153
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of esomeprazole for treatment of poorly controlled asthma.
; Mastronarde JG; Anthonisen NR; Castro M; Holbrook JT; Leone FT; Teague WG; Wise RA
N Engl J Med; 2009 Apr; 360(15):1487-99. PubMed ID: 19357404
[TBL] [Abstract][Full Text] [Related]
16. Predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease.
Wang AJ; Wang H; Xu L; Lv NH; He XX; Hong JB; You Y; Zhu X
Dig Liver Dis; 2013 Apr; 45(4):296-300. PubMed ID: 23333666
[TBL] [Abstract][Full Text] [Related]
17. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.
Grigolon A; Cantù P; Savojardo D; Conte D; Penagini R
J Clin Gastroenterol; 2008 Oct; 42(9):969-73. PubMed ID: 18719508
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Acid-suppressive Effects of Esomeprazole in Infants 1-24 Months Old With Symptoms of Gastroesophageal Reflux Disease.
Omari T; Davidson G; Bondarov P; Nauclér E; Nilsson C; Lundborg P
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S2-8. PubMed ID: 26422094
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Acid-suppressive Effects of Esomeprazole in Infants 1-24 Months Old With Symptoms of Gastroesophageal Reflux Disease.
Omari T; Davidson G; Bondarov P; Nauclér E; Nilsson C; Lundborg P
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S2-8. PubMed ID: 26121346
[TBL] [Abstract][Full Text] [Related]
20. Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritis.
Sun J; Yuan YZ; Hou XH; Zou DW; Lu B; Chen MH; Liu F; Wu KC; Zou XP; Li YQ; Zhou LY
World J Gastroenterol; 2015 Jun; 21(22):6965-73. PubMed ID: 26078574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
